Low Mean Platelet Volume is Associated with Deep Vein Thrombosis in Older Patients with Hip Fracture

Clin Appl Thromb Hemost. 2022 Jan-Dec:28:10760296221078837. doi: 10.1177/10760296221078837.

Abstract

This study aimed to explore the association between mean platelet volume (MPV) and preoperative deep vein thrombosis (DVT) in older patients with hip fracture. A total of 352 consecutive older patients with hip fracture were included from January 2014 to December 2020. MPV values were measured on admission, and color Doppler ultrasonography was performed for DVT screening before the planned surgery. The receiver operating characteristic (ROC) curve was used to establish the optimal cut-off value for the prediction of DVT. Univariate and multivariate logistic regression analysis were used to examine the association between factors and DVT. The overall prevalence of preoperative DVT was 15.1%, and patients with DVT had a lower value of MPV than non-DVT patients (11.6 ± 1.2 fL vs 12.3 ± 1.4 fL, P < .01). The cut-off point according to the ROC curve for MPV was 13.3 fL, and multivariate logistic regression analysis showed that MPV level < 13.3 fL was significantly associated with an increased risk of DVT (OR = 4.857, 95% CI: 1.091-21.617, P = .038), and with every 1.0 fL decrease in MPV, the risk increased by 27.7% (OR = 1.277, 95% CI: 1.001-1.629, P = .047). Our findings indicate that a low MPV level is associated with DVT in older patients with hip fracture. As MPV is a simple indicator that can be calculated from the blood routine test, it may be a potential biomarker of DVT with the combination of other tests, further studies are needed to confirm these results.

Keywords: deep vein thrombosis; hip fracture; mean platelet volume; older adults.

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Biomarkers
  • Body Mass Index
  • Case-Control Studies
  • Comorbidity
  • Female
  • Hip Fractures / blood*
  • Humans
  • Male
  • Mean Platelet Volume / statistics & numerical data*
  • Middle Aged
  • ROC Curve
  • Retrospective Studies
  • Risk Factors
  • Sex Factors
  • Ultrasonography, Doppler
  • Venous Thrombosis / blood*

Substances

  • Biomarkers